{"article_title": "In Reversal, Valeant CEO to Be Deposed by Senate Panel", "article_keywords": ["scheduled", "pearson", "statement", "joint", "susan", "ceo", "deposed", "valeant", "proceedings", "hearing", "senate", "deposition", "reversal", "subpoenaed", "today", "panel"], "article_url": "https://morningconsult.com/alert/reversal-valeant-ceo-deposed-senate-panel/", "article_text": "The Senate Special Committee on Aging will depose the CEO of Valeant Pharmaceuticals next week, rather than begin proceedings to hold him in contempt today.\n\nValeant CEO Michael Pearson will attend a deposition on Monday, Sens. Susan Susan Collins (R-Maine.) and Claire McCaskill (D-Mo.), the committee\u2019s leaders, said today in a joint statement. The two had scheduled a business meeting for today to consider opening contempt proceedings against Pearson after he did not attend a deposition he had been subpoenaed for last week.\n\n\u201cThe deposition has been scheduled for Monday April 18th and we look forward to hearing Mr. Pearson\u2019s testimony,\u201d they said in a joint statement. \u201cThis deposition and investigation are about better understanding the dramatic price increases we\u2019re seeing for decades old prescription drugs and how those prices are affecting consumers\u2014and we\u2019re committed to being thorough in that pursuit.\u201d\n\nPearson has also been subpoenaed to appear for a hearing before the full committee on April 27.", "article_metadata": {"msapplication-config": "/icons/browserconfig.xml", "viewport": "width=device-width, initial-scale=1", "og": {"site_name": "Morning Consult", "description": "The Senate Special\u00a0Committee on Aging will depose\u00a0the CEO of Valeant Pharmaceuticals next\u00a0week, rather than begin proceedings to hold him in contempt today. Valeant CEO Michael Pearson will attend a deposition on Monday, Sens.\u00a0Susan Susan Collins (R-Maine.) and Claire McCaskill (D-Mo.), the committee\u2019s leaders, said today in a joint statement. The two had scheduled a business... read more", "title": "In Reversal, Valeant CEO to Be Deposed by Senate Panel - Morning Consult", "locale": "en_US", "image": "https://morningconsult.com/wp-content/themes/morning-consult/img/MC_logo_twitter_fb.png", "url": "https://morningconsult.com/alert/reversal-valeant-ceo-deposed-senate-panel/", "type": "article"}, "twitter": {"description": "The Senate Special\u00a0Committee on Aging will depose\u00a0the CEO of Valeant Pharmaceuticals next\u00a0week, rather than begin proceedings to hold him in contempt today. Valeant CEO Michael Pearson will attend a deposition on Monday, Sens.\u00a0Susan Susan Collins (R-Maine.) and Claire McCaskill (D-Mo.), the committee\u2019s leaders, said today in a joint statement. The two had scheduled a business... read more", "creator": "@melmcintire", "image": "https://morningconsult.com/wp-content/themes/morning-consult/img/MC_logo_twitter_fb.png", "title": "In Reversal, Valeant CEO to Be Deposed by Senate Panel - Morning Consult", "site": "@morningconsult", "card": "summary"}, "msapplication-TileColor": "#2b5797", "msapplication-TileImage": "/icons/mstile-144x144.png", "article": {"publisher": "https://www.facebook.com/Morning-Consult-183517831660100/", "section": "Health"}, "theme-color": "#ffffff"}, "article_summary": "Susan Susan Collins (R-Maine.)\nThe Senate Special Committee on Aging will depose the CEO of Valeant Pharmaceuticals next week, rather than begin proceedings to hold him in contempt today.\nValeant CEO Michael Pearson will attend a deposition on Monday, Sens.\n), the committee\u2019s leaders, said today in a joint statement.\n\u201cThe deposition has been scheduled for Monday April 18th and we look forward to hearing Mr. Pearson\u2019s testimony,\u201d they said in a joint statement."}